Cytokinetics | CYTK - Operating Profit



Cytokinetics reported $-111506000 in Operating Profit for its fiscal quarter ending in June of 2025.


Operating Profit Change Date
Acadia Pharmaceuticals USD 32.37M 13.08M Jun/2025
Amgen USD 2.66B 1.37B Jun/2025
Bayer EUR 13M 2.31B Jun/2025
Biogen USD 851.8M 540.6M Jun/2025
Bristol-Myers Squibb USD 3.77B 366M Jun/2025
Cytokinetics USD -111506000 44.12M Jun/2025
Eisai JPY 20.74B 21.77B Jun/2025
Eli Lilly USD 7.02B 1.61B Jun/2025
Exelixis USD 215.68M 28.82M Jul/2025
Geron USD -12454000 4.25M Jun/2025
Halozyme Therapeutics USD 202.44M 60.91M Jun/2025
Ionis Pharmaceuticals USD 139.84M 285.84M Jun/2025
Ligand Pharmaceuticals USD 43.56M 79.78M Jun/2025
Merck USD 6.36B 494M Jun/2025
Novartis USD 4.86B 201M Jun/2025
Pfizer USD 2.6B 1.06B Jun/2025
Regeneron Pharmaceuticals USD 1.08B 487.8M Jun/2025
Roche Holding CHF 4.39B 1.04B Dec/2024
Sanofi EUR 1.71B 573M Jun/2025